[
    {
        "Type of cases ": "NSP Cured",
        "I Qtr-2022": "267",
        "II Qtr-2022": "205",
        "III Qtr-2022": "299",
        "IV Qtr-2022": "266",
        "Total 2022": "1037",
        "%": "83.4"
    },
    {
        "Type of cases ": "NSP Treatment completed",
        "I Qtr-2022": "1",
        "II Qtr-2022": "2",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "3",
        "Total 2022": "6",
        "%": "0.5"
    },
    {
        "Type of cases ": "NSP Died",
        "I Qtr-2022": "12",
        "II Qtr-2022": "7",
        "III Qtr-2022": "17",
        "IV Qtr-2022": "18",
        "Total 2022": "54",
        "%": "4.3"
    },
    {
        "Type of cases ": "NSP Failure",
        "I Qtr-2022": "4",
        "II Qtr-2022": "6",
        "III Qtr-2022": "7",
        "IV Qtr-2022": "5",
        "Total 2022": "22",
        "%": "1.8"
    },
    {
        "Type of cases ": "NSP Lost to Follow-up",
        "I Qtr-2022": "8",
        "II Qtr-2022": "6",
        "III Qtr-2022": "4",
        "IV Qtr-2022": "8",
        "Total 2022": "26",
        "%": "2.1"
    },
    {
        "Type of cases ": "NSP Not Evaluated",
        "I Qtr-2022": "1",
        "II Qtr-2022": "3",
        "III Qtr-2022": "1",
        "IV Qtr-2022": "7",
        "Total 2022": "12",
        "%": "1.0"
    },
    {
        "Type of cases ": "NSP Treatment Regimen Changed",
        "I Qtr-2022": "28",
        "II Qtr-2022": "17",
        "III Qtr-2022": "26",
        "IV Qtr-2022": "15",
        "Total 2022": "86",
        "%": "6.9"
    },
    {
        "Type of cases ": "NSP Total",
        "I Qtr-2022": "321",
        "II Qtr-2022": "246",
        "III Qtr-2022": "354",
        "IV Qtr-2022": "322",
        "Total 2022": "1243",
        "%": ""
    },
    {
        "Type of cases ": "NSN/NEP Cured",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "NSN/NEP Treatment completed",
        "I Qtr-2022": "567",
        "II Qtr-2022": "407",
        "III Qtr-2022": "557",
        "IV Qtr-2022": "579",
        "Total 2022": "2110",
        "%": "95.9"
    },
    {
        "Type of cases ": "NSN/NEP Died",
        "I Qtr-2022": "5",
        "II Qtr-2022": "10",
        "III Qtr-2022": "15",
        "IV Qtr-2022": "14",
        "Total 2022": "44",
        "%": "2.0"
    },
    {
        "Type of cases ": "NSN/NEP Failure",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "1",
        "Total 2022": "1",
        "%": "0.0"
    },
    {
        "Type of cases ": "NSN/NEP Lost to Follow-up",
        "I Qtr-2022": "9",
        "II Qtr-2022": "3",
        "III Qtr-2022": "9",
        "IV Qtr-2022": "14",
        "Total 2022": "35",
        "%": "1.6"
    },
    {
        "Type of cases ": "NSN/NEP Not Evaluated",
        "I Qtr-2022": "4",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "4",
        "%": "0.2"
    },
    {
        "Type of cases ": "NSN/NEP Treatment Regimen Changed",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "4",
        "IV Qtr-2022": "3",
        "Total 2022": "7",
        "%": "0.3"
    },
    {
        "Type of cases ": "NSN/NEP Total",
        "I Qtr-2022": "585",
        "II Qtr-2022": "420",
        "III Qtr-2022": "585",
        "IV Qtr-2022": "611",
        "Total 2022": "2201",
        "%": ""
    },
    {
        "Type of cases ": "RT +ve Cured",
        "I Qtr-2022": "65",
        "II Qtr-2022": "65",
        "III Qtr-2022": "78",
        "IV Qtr-2022": "64",
        "Total 2022": "272",
        "%": "78.4"
    },
    {
        "Type of cases ": "RT+ve Treatment completed",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "RT +Ve Died",
        "I Qtr-2022": "5",
        "II Qtr-2022": "7",
        "III Qtr-2022": "6",
        "IV Qtr-2022": "5",
        "Total 2022": "23",
        "%": "6.6"
    },
    {
        "Type of cases ": "RT +ve Failure",
        "I Qtr-2022": "2",
        "II Qtr-2022": "0",
        "III Qtr-2022": "1",
        "IV Qtr-2022": "3",
        "Total 2022": "6",
        "%": "1.7"
    },
    {
        "Type of cases ": "RT +ve Lost to Follow-up",
        "I Qtr-2022": "3",
        "II Qtr-2022": "1",
        "III Qtr-2022": "4",
        "IV Qtr-2022": "7",
        "Total 2022": "15",
        "%": "4.3"
    },
    {
        "Type of cases ": "RT +ve Not Evaluated",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "RT +ve Treatment Regimen Changed",
        "I Qtr-2022": "4",
        "II Qtr-2022": "9",
        "III Qtr-2022": "8",
        "IV Qtr-2022": "10",
        "Total 2022": "31",
        "%": "8.9"
    },
    {
        "Type of cases ": "RT +ve Total",
        "I Qtr-2022": "79",
        "II Qtr-2022": "82",
        "III Qtr-2022": "97",
        "IV Qtr-2022": "89",
        "Total 2022": "347",
        "%": ""
    },
    {
        "Type of cases ": "RT Neg Cured",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "RT Neg Treatment completed",
        "I Qtr-2022": "92",
        "II Qtr-2022": "44",
        "III Qtr-2022": "91",
        "IV Qtr-2022": "97",
        "Total 2022": "324",
        "%": "93.4"
    },
    {
        "Type of cases ": "RT Neg Died",
        "I Qtr-2022": "1",
        "II Qtr-2022": "0",
        "III Qtr-2022": "6",
        "IV Qtr-2022": "5",
        "Total 2022": "12",
        "%": "3.5"
    },
    {
        "Type of cases ": "RT Neg Failure",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "RT Neg Lost to Follow-up",
        "I Qtr-2022": "4",
        "II Qtr-2022": "3",
        "III Qtr-2022": "3",
        "IV Qtr-2022": "1",
        "Total 2022": "11",
        "%": "3.2"
    },
    {
        "Type of cases ": "RT Neg Not Evaluated",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "RT Neg Treatment Regimen Changed",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "RT Neg Total",
        "I Qtr-2022": "97",
        "II Qtr-2022": "47",
        "III Qtr-2022": "100",
        "IV Qtr-2022": "103",
        "Total 2022": "347",
        "%": ""
    }
]